Select your Region     
Therapeutic Strategies in Pulmonary Arterial Hypertension

Price: £49.99
• Applies structured case study approach to new oncology discipline • Suitable for reference at point of care • Ideal for learning and CPD
Edited by:
A Peacock, Director, Scottish Pulmonary Vascular Unit, Western Infirmary, Glasgow, Scotland; J Barberà, Dept of Pulmonary Medicine, Institute of Biomedical Research Augusti Pi i Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona, Spain.
Pulmonary arterial hypertension (PAH) is a rare condition; yet this very rarity can be a disadvantage when it comes to treatment, making PAH difficult to diagnose, and resulting in suboptimal patient care. Furthermore, the global burden of PAH remains poorly understood and largely underestimated, as PAH commonly presents as a comorbidity with such conditions as systemic sclerosis, COPD, idiopathic pulmonary fibrosis and left-heart dysfunction. However, in recent years there has been significant investment in developing new therapies for PAH, and treatment for this previously neglected disease is set to enter a new era. This new work draws on the recent published literature and clinical trials to review the latest developments in our understanding of the disease, new advances in therapy and current opinion on best practice approaches to management. Internationally-recognised authorities on PAH provide expert analysis of these advances and critical commentary on the data presented to help explain the implications of these findings for future clinical practice.
• Specialists in oncology • general physicians • doctors in training • oncology nurses • healthcare managers and administrators

Book Details:
978 1 84692 053 0
112pp; 240 x 170mm; Illustrations; Hardback;
Publication Date: April 2009

Privacy Policy | Terms and Conditions of Sale